QSAR studies on imidazopyridazine derivatives as PfPK7 inhibitors

Molecular Simulation

Volumn 37, Issue 9, 2011, Pages 752-765

  Sahu, Nitendra K ^a   Shahi, Sadhana ^b   Sharma, Mukesh C ^a   Kohli, D V ^a  

^a DR H S GOUR UNIVERSITY   (India)

^b GOVERNMENT COLLEGE OF PHARMACY   (India)

Author keywords

imidazopyridazines; molecular field analysis (MFA); partial least square (PLS); PfPK7; quantitative structure activity relationship (QSAR)

Indexed keywords

IMIDAZOPYRIDAZINES; MOLECULAR FIELD ANALYSIS (MFA); PARTIAL LEAST SQUARES; PFPK7; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP (QSAR);

ENZYMES; FEATURE EXTRACTION; GENETIC ALGORITHMS; LEAST SQUARES APPROXIMATIONS; MOLECULAR GRAPHICS; SIMULATED ANNEALING; THREE DIMENSIONAL;

COMPUTATIONAL CHEMISTRY;

EID: 79960733970     PISSN: 08927022     EISSN: 10290435     Source Type: Journal    
DOI: 10.1080/08927022.2010.547050     Document Type: Article

References (37)

1. M. Aregawi, R. Cibulskis, M. Otten, R. Williams, and C. Dye, World Malaria Report, World Health Organization, Geneva, 2008.
2. Global malaria action plan, [online]. Available at: http://rbm.who.int/ gmap/gmap.pdf, pp. 85-87
3. S. Nwaka and A. Hudson, Innovative lead discovery strategies for tropical diseases, Nat. Rev. Drug Discov. 5 (2006), pp. 941-955. (Pubitemid 44660607)
4. N. K. Sahu, S. Sahu, and D. V. Kohli, Novel molecular targets for antimalarial drug development, Chem. Biol. Drug Des. 71 (2008), pp. 287-297. (Pubitemid 351347791)
5. N. Bouloc, M. Jonathan, E. S. Large, W. David, H. Keith, C. D. Ansell, and S. B. Justin, Synthesis and in vitro evaluation of imidazopyridazines as novel inhibitors of the malarial kinase PfPK7, Bioorg. Med. Chem. Lett. 18 (2008), pp. 5294-5298.
6. A. Merckx, A. Echalier, K. Langford, A. Sicard, G. Langsley, J. Joore, C. Doerig, M. Noble, and J. Endicott, Structures of P. falciparum protein kinase 7 identify an activation motif and leads for inhibitor design, Structure 16 (2008), pp. 228-238. (Pubitemid 351222652)
7. D. Dorin, J. Semblat, P. Poullet, P. Alano, J. P. D. Goldring, C. Whittle, S. Patterson, D. Chakrabarti, and C. Doerig, PfPK7, an atypical MEK-related protein kinase, reflects the absence of classical three-component MAPK pathways in the human malaria parasite Plasmodium falciparum, Mol. Microbiol. 55 (2005), pp. 184-196. (Pubitemid 40127895)
8. V. K. Agrawal, R. Srivastava, and P. V. Khadikar, QSAR studies on some antimalarial sulfonamides, Bioorg. Med. Chem. 9 (2001), pp. 287-293.
9. C. X. Xue, S. Y. Cui, M. C. Liu, Z. D. Hu, and B. T. Fan, 3D QSAR studies on antimalarial alkoxylated and hydroxylated chalcones by CoMFA and CoMSIA, Eur. J. Med. Chem. 39 (2004), pp. 745-753. (Pubitemid 39165159)
10. M. Zahouily, M. Lazar, A. Elmakssoudi, J. Rakik, S. Elaychi, and A. Rayadh, QSAR for anti-malarial activity of 2-aziridinyl and 2, 3-bis (aziridinyl)-1, 4-naphthoquinonyl sulfonate and acylate derivatives, J. Mol. Model. 12 (2006), pp. 398-405. (Pubitemid 43337177)
11. M. Srivastava, H. Singh, and P. K. Naik, Quantitative structure-activity relationship (QSAR) of artemisinin: The development of predictive in vivo antimalarial activity models, J. Chemom. 23 (2009), pp. 618-635.
12. A. Xie, S. R. Clark, S. Prasanna, and R. J. Doerksen, Three-dimensional quantitative structure-farnesyltransferase inhibition analysis for some diaminobenzophenones, J. Enzyme Inhib. Med. Chem. 24 (2009), pp. 1220-1228.
13. A. Xie, S. R. Clark, S. Prasanna, and R. J. Doerksen, Imidazolecontaining farnesyltransferase inhibitors: 3D quantitative structure-activity relationships and molecular docking, J. Comput. Aided Mol. Des. 23 (2009), pp. 431-448.
14. C. Hansch, A quantitative approach to biochemical structure-activity relationships, Acc. Chem. Res. 2 (1969), p. 232.
15. A. M. Doweyko, QSAR: Dead or alive? J. Comput. Aided Mol. Des. 22 (2008), pp. 81-89.
16. T. Scior, J. L. Medina-Franco, Q.-T. Do, K. Martínez-Mayorga, J. A. Yunes Rojas, and P. Bernard, How to recognize and workaround pitfalls in QSAR studies: A critical review, Curr. Med. Chem. 16 (2009), pp. 4297-4313.
17. Molecular design suite 3.5, VLife Technologies, Pune, India. Available at: www.vlifesciences.com
18. T. A. Halgren, Merck molecular force field. III. Molecular geometries and vibrational frequencies for MMFF94, J. Comput. Chem. 17 (1996), pp. 553-586. (Pubitemid 126567069)
19. A. Golbraikh and A. Tropsha, Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection, J. Comput. Aided Mol. Des. 16 (2002), pp. 357-369. (Pubitemid 35414668)
20. S. Ajmani, K. Jadhav, and S. A. Kulkarni, Three-dimensional QSAR using the k-nearest neighbor method and its interpretation, J. Chem. Inf. Model. 46 (2006), pp. 24-31. (Pubitemid 43282095)
21. R. D. Cramer, D. E. Patterson, and J. D. Bunce, Comparative molecular field analysis (CoMFA) 1. Effect of shape on binding of steroids to carrier proteins, J. Am. Chem. Soc. 110 (1988), pp. 5959-5967.
22. G. Klebe, U. Abraham, and T. Mietzner, Molecular similarity indexes in a comparative-analysis (CoMSIA) of drug molecules to correlate and predict their biological-activity, J. Med. Chem. 37 (1994), pp. 4130-4146. (Pubitemid 24379702)
23. P. Ghosh and M. C. Bagchi, QSAR modeling for quinoxaline derivatives using genetic algorithm and simulated annealing based feature selection, Curr. Med. Chem. 16 (2009), pp. 4032-4048.
24. M. Shen, Y. Xiao, A. Golbraikh, V. K. Gombar, and A. Tropsha, Development and validation of k-nearest-neighbor QSPR models of metabolic stability of drug candidates, J. Med. Chem. 46 (2003), pp. 3013-3020. (Pubitemid 36775924)
25. I. Guyon and A. Elisseeff, An introduction to variable and feature selection, J. Mach. Learn. Res. 3 (2003), pp. 1157-1182.
26. R. B. Darlington, Regression and Linear Models, McGraw-Hill, New York, 1990.
27. K. Hasegawa, T. Kimura, and K. Funatsu, GA strategy for variable selection in QSAR studies: Enhancement of comparative molecular binding energy analysis by GA-based PLS method, Quant. Struct. Act. Relat. 18 (1999), pp. 262-272. (Pubitemid 29364073)
28. W. Zheng and A. Tropsha, Novel variable selection quantitative structure-property relationship approach based on the k-nearestneighbor principle, J. Chem. Inf. Comput. Sci. 40 (2000), pp. 185-194.
29. J. H. Holland, Genetic algorithms, Sci. Am. 267 (1992), pp. 66-72. (Pubitemid 23236500)
30. A. R. Leach and V. J. Gillet, An Introduction to Chemoinformatics, Kluwer Academic Publishers, Boston, MA, 2003.
31. P. Ghosh and M. C. Bagchi, Comparative QSAR studies of nitrofuranyl amide derivatives using theoretical structural properties, Mol. Simul. 35 (14) (2009), pp. 1185-1200.
32. S. Wold, in PLS for Multivariate Linear Modeling, H. van de Waterbeemd, ed., VCH, Weinheim, 1995, pp. 195-218.
33. 2!, J. Mol. Graph. Model. 20 (2002), pp. 269-276. (Pubitemid 34017544)
34. A. Afantitis, G. Melagraki, H. Sarimveis, O. Igglessi-Markopoulou, and G. A. Kolliasnovel, QSAR model for predicting the inhibition of CXCR3 receptor by 4-N-aryl-[1, 4] diazepane ureas, Eur. J. Med. Chem. 44 (2009), pp. 877-884.
35. P. Sarmah and C. Deka, DFT-based QSAR and QSPR models of several cis-platinum complexes: Solvent effect, J. Comput. Aided Mol. Des. 23 (2009), pp. 343-354.
36. W. Samee, P. Nunthanavanit, and J. Ungwitayatorn, 3D-QSAR investigation of synthetic antioxidant chromone derivatives by molecular field analysis, Int. J. Mol. Sci. 9 (2008), pp. 235-246. (Pubitemid 351482112)
37. S. Nandi and M. C. Bagchi, 3D-QSAR and molecular docking studies of 4-anilinoquinazoline derivatives: A rational approach to anticancer drug design, Mol. Divers. 14 (2010), pp. 27-38.